The addition of interleukin-2 to cyclophosphamide therapy can facilitate tumor growth of B16 melanoma. [electronic resource]
Producer: 19950807Description: 292-8 p. digitalISSN:- 0340-7004
- Animals
- Combined Modality Therapy -- adverse effects
- Cyclophosphamide -- administration & dosage
- Drug Interactions
- Female
- Immunocompetence
- Immunocompromised Host
- Immunologic Factors -- administration & dosage
- Injections
- Interleukin-2 -- administration & dosage
- Liver Neoplasms -- drug therapy
- Melanoma, Experimental -- drug therapy
- Mice
- Mice, Inbred C57BL
- Neoplasm Proteins -- metabolism
- Neoplasm Transplantation
- Receptors, Interleukin-2 -- drug effects
- Spleen
- Whole-Body Irradiation -- adverse effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.